Scarica l'app Stockscreener
26.31
0.53%
-0.14
Dopo l'orario di chiusura:
26.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$26.45
Aprire:
$26.05
Volume 24 ore:
171.03K
Relative Volume:
0.46
Capitalizzazione di mercato:
$325.80M
Reddito:
$9.71M
Utile/perdita netta:
$-29.96M
Rapporto P/E:
-7.5603
EPS:
-3.48
Flusso di cassa netto:
$-14.79M
1 W Prestazione:
-1.68%
1M Prestazione:
+5.58%
6M Prestazione:
-25.34%
1 anno Prestazione:
+21.81%
Intervallo 1D:
$26.05
$27.42
Intervallo di 1 settimana:
$24.48
$27.42
Portata 52W:
$18.35
$39.92
Xoma Royalty Corp Stock (XOMA) Company Profile
Nome
Xoma Royalty Corp
Settore
Industria
Telefono
510-204-7239
Indirizzo
2200 POWELL STREET, EMERYVILLE, CA
Compare XOMA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
26.31 | 327.53M | 9.71M | -29.96M | -14.79M | -3.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-17 | Iniziato | The Benchmark Company | Buy |
| 2024-04-29 | Iniziato | Leerink Partners | Outperform |
| 2021-09-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-06-29 | Iniziato | Aegis Capital | Buy |
| 2021-01-19 | Reiterato | H.C. Wainwright | Buy |
| 2018-01-18 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-17 | Ripresa | H.C. Wainwright | Buy |
| 2017-09-05 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2017-06-12 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-14 | Downgrade | Wedbush | Outperform → Neutral |
| 2016-03-11 | Reiterato | Wedbush | Outperform |
| 2015-07-23 | Downgrade | Jefferies | Buy → Hold |
| 2015-07-22 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | Ripresa | ROTH Capital | Buy |
| 2014-04-29 | Aggiornamento | MLV & Co | Hold → Buy |
| 2014-03-11 | Downgrade | MLV & Co | Buy → Hold |
| 2014-03-05 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-10-31 | Reiterato | MLV & Co | Buy |
| 2013-05-09 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-05-14 | Iniziato | Cowen & Co | Outperform |
| 2011-03-31 | Reiterato | MLV Capital | Buy |
| 2011-03-23 | Reiterato | RBC Capital Mkts | Outperform |
| 2011-01-06 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-01-04 | Reiterato | Wedbush | Outperform |
Mostra tutto
Xoma Royalty Corp Borsa (XOMA) Ultime notizie
Layoff Watch: Why is XOMA Royalty Corporation stock going downJuly 2025 WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
XOMA Royalty Corporation (NASDAQ:XOMA) Short Interest Update - MarketBeat
XOMA (NASDAQ: XOMA) details 2025 royalty cash, buybacks and litigation costs - Stock Titan
LVTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
XOMA Royalty Corporation (NASDAQ:XOMA) Receives $60.60 Average Price Target from Brokerages - Defense World
What Analysts Are Saying About XOMA Royalty Stock - Sahm
Leerink raises Xoma stock price target on royalty outlook - Investing.com
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
MURAMural Oncology PLC Latest Stock News & Market Updates - Stock Titan
XOMA Royalty to Present at Investor Conferences in March - 富途牛牛
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right - Intellectia AI
Biotech royalty player XOMA lines up March investor talks - Stock Titan
Short Interest in XOMA Royalty Corporation (NASDAQ:XOMA) Grows By 27.4% - MarketBeat
What drives XOMA Royalty Corporation’s stock priceJuly 2025 Gainers & Smart Swing Trading Alerts - mfd.ru
XOMA Royalty (NASDAQ:XOMA) Upgraded by TD Cowen to "Hold" Rating - MarketBeat
Why XOMA Royalty Corporation stock is rated strong buyJuly 2025 Outlook & Verified Swing Trading Watchlists - mfd.ru
XOMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Xoma stock rating reinstated as Hold by TD Cowen after Generation Bio acquisition - Investing.com South Africa
Buyback Watch: What drives XOMA Royalty Corporations stock priceJuly 2025 Market Mood & Risk Controlled Stock Alerts - baoquankhu1.vn
XOMA Royalty (NASDAQ:XOMA) Upgraded at Zacks Research - Defense World
XOMA Royalty (NASDAQ:XOMA) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
XOMA Royalty’s Preferreds Still Offer Compelling Income Despite Call Risk (NASDAQ:XOMA) - Seeking Alpha
Generation Bio pays landlord $21.5M to escape lease early after Xoma buyout - The Business Journals
XOMA Completes Acquisition and Delisting of Generation Bio - The Globe and Mail
XOMA Royalty completes acquisition of Generation Bio for $4.29 per share By Investing.com - Investing.com South Africa
XOMA Royalty completes acquisition of Generation Bio for $4.29 per share - Investing.com Nigeria
XOMA Royalty completes acquisition of Generation Bio; GBIO delisted from Nasdaq - Investing.com
XOMA Royalty Completes Generation Bio Acquisition and Merger - TipRanks
XOMA Royalty Corporation Completes Acquisition of Generation Bio Co. Through Tender Offer - Quiver Quantitative
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. - GlobeNewswire
Generation Bio (GBIO) director equity cashed out in XOMA acquisition - Stock Titan
Published on: 2026-02-09 02:34:15 - baoquankhu1.vn
Gainers Report: What is the next catalyst for XOMA Royalty CorporationShare Buyback & Accurate Intraday Trading Signals - baoquankhu1.vn
Analysts Set XOMA Royalty Corporation (NASDAQ:XOMA) Target Price at $60.60 - Defense World
Short Interest in XOMA Royalty Corporation (NASDAQ:XOMA) Grows By 56.7% - MarketBeat
XOMA Royalty Corporation (NASDAQ:XOMA) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Analyzing XOMA Royalty (NASDAQ:XOMA) and Ascendis Pharma A/S (NASDAQ:ASND) - Defense World
Risk Off: What is the next catalyst for XOMA Royalty Corporation2025 Volume Leaders & Short-Term High Return Strategies - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - GlobeNewswire Inc.
Institutional owners may take dramatic actions as XOMA Royalty Corporation's (NASDAQ:XOMA) recent 12% drop adds to one-year losses - Yahoo Finance
XOMA Royalty Appoints New Chief Financial Officer - The Globe and Mail
Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty CorporationXOMA - marketscreener.com
XOMA Royalty Corp (NASDAQ: XOMA) appoints new CFO, sets pay terms - stocktitan.net
XOMA Royalty CFO Thomas Burns steps down, Jeffrey Trigilio appointed - Investing.com
XOMA royalty announces CFO transition - MSN
XOMA Royalty Corporation Announces CFO Transition as Thomas Burns Steps Down and Jeffrey Trigilio Takes Over - Quiver Quantitative
Biotech royalty firm XOMA shifts finance leadership after nearly 20 years - Stock Titan
Is XOMA Royalty Corporation stock a defensive play in 20252025 Investor Takeaways & Reliable Price Breakout Signals - Улправда
Will XOMA Royalty Corporation (X0M1) stock profit from fiscal stimulus2026 world cup usa national team quarterfinals top scorers counter attacking tactical prediction breakdown - ulpravda.ru
Implied Volatility Surging for XOMA Royalty Stock Options - Yahoo Finance
XOMA Royalty Corporation (NASDAQ:XOMA) Given Average Rating of “Hold” by Analysts - Defense World
Xoma Royalty Corp Azioni (XOMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.69%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):